Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of Remicade in Chronic Beryllium Disease: A Randomized, Double-Blind, Placebo-Controlled, Investigator Initiated Trial

NCT00111917 is registered in ClinicalTrials.gov with Maier, Lisa, M.D. as lead sponsor.

NCT NCT00111917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00111917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of Remicade in Chronic Beryllium Disease: A Randomized, Double-Blind, Placebo-Controlled, Investigator Initiated Trial
Lead sponsor
Maier, Lisa, M.D.
Phase
Phase 1/2
Overall status
Terminated
Start date
February 28, 2005
Completion date
January 31, 2009
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

berylliosis, beryllium disease